Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinlei Mi

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|July 13, 2023
Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC)Devalingam Mahalingam, Siqi Chen, Ping Xie, et al.
Scientific Reports|January 31, 2024
Incorporating longitudinal history of risk factors into atherosclerotic cardiovascular disease risk prediction using deep learningJingzhi Yu, Xiaoyun Yang, Yu Deng, et al.
Research Square|October 27, 2023
Incorporating longitudinal history of risk factors into atherosclerotic cardiovascular disease risk prediction using deep learningJingzhi Yu, Xiaoyun Yang, Yu Deng, et al.
Prostate Cancer and Prostatic Diseases|June 10, 2024
Detection of clinically significant prostate cancer following initial omission of biopsy in multiparametric MRI eraEric V Li, Anna M Busza, Mohammad R Siddiqui, et al.
World Journal of Urology|February 26, 2026
Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort studyConor B Driscoll, Jordan M Rich, Christopher Yang, et al.
Journal of Inflammation (London, England)|August 15, 2025
Long-term risk of de novo malignancy with tumor necrosis factor alpha (TNF) inhibitor immunosuppression: a multicenter, retrospective cohort studyConor B Driscoll, Jordan M Rich, Christopher Yang, et al.
Blood Advances|September 27, 2023
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphomaReem Karmali, Jeremy S Abramson, Deborah M Stephens, et al.
Prostate Cancer and Prostatic Diseases|May 13, 2022
Real-world use of MRI for risk stratification prior to prostate biopsyMohammad R Siddiqui, Brandon Ansbro, Parth V Shah, et al.
Blood Advances|January 18, 2024
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimenReem Karmali, Carlos Galvez, Mehdi Hamadani, et al.
Anesthesia and Analgesia|February 16, 2021
Slow Dynamics of Acute Postoperative Pain Intensity Time Series Determined via Wavelet Analysis Are Associated With the Risk of Severe Postoperative Day 30 PainRaheleh Baharloo, Jose C Principe, Roger B Fillingim, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|July 13, 2023
Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC)Devalingam Mahalingam, Siqi Chen, Ping Xie, et al.
Scientific Reports|January 31, 2024
Incorporating longitudinal history of risk factors into atherosclerotic cardiovascular disease risk prediction using deep learningJingzhi Yu, Xiaoyun Yang, Yu Deng, et al.
Research Square|October 27, 2023
Incorporating longitudinal history of risk factors into atherosclerotic cardiovascular disease risk prediction using deep learningJingzhi Yu, Xiaoyun Yang, Yu Deng, et al.
Prostate Cancer and Prostatic Diseases|June 10, 2024
Detection of clinically significant prostate cancer following initial omission of biopsy in multiparametric MRI eraEric V Li, Anna M Busza, Mohammad R Siddiqui, et al.
World Journal of Urology|February 26, 2026
Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort studyConor B Driscoll, Jordan M Rich, Christopher Yang, et al.
Journal of Inflammation (London, England)|August 15, 2025
Long-term risk of de novo malignancy with tumor necrosis factor alpha (TNF) inhibitor immunosuppression: a multicenter, retrospective cohort studyConor B Driscoll, Jordan M Rich, Christopher Yang, et al.
Blood Advances|September 27, 2023
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphomaReem Karmali, Jeremy S Abramson, Deborah M Stephens, et al.
Prostate Cancer and Prostatic Diseases|May 13, 2022
Real-world use of MRI for risk stratification prior to prostate biopsyMohammad R Siddiqui, Brandon Ansbro, Parth V Shah, et al.
Blood Advances|January 18, 2024
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimenReem Karmali, Carlos Galvez, Mehdi Hamadani, et al.
Anesthesia and Analgesia|February 16, 2021
Slow Dynamics of Acute Postoperative Pain Intensity Time Series Determined via Wavelet Analysis Are Associated With the Risk of Severe Postoperative Day 30 PainRaheleh Baharloo, Jose C Principe, Roger B Fillingim, et al.
Pageof 5